Equities researchers at HC Wainwright initiated coverage on shares of SeaSpine Holdings Corporation (NASDAQ:SPNE) in a report issued on Monday, July 10th, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $15.00 price target on the medical equipment provider’s stock. HC Wainwright’s price target points to a potential upside of 15.83% from the company’s previous close.

A number of other equities research analysts also recently issued reports on SPNE. ValuEngine upgraded shares of SeaSpine Holdings Corporation from a “strong sell” rating to a “sell” rating in a research note on Friday, June 2nd. BTIG Research started coverage on shares of SeaSpine Holdings Corporation in a research note on Tuesday, June 20th. They set a “buy” rating on the stock.

Shares of SeaSpine Holdings Corporation (SPNE) traded up 12.61% during midday trading on Monday, hitting $12.95. The stock had a trading volume of 69,027 shares. The company’s market cap is $152.02 million. SeaSpine Holdings Corporation has a one year low of $6.31 and a one year high of $13.46. The firm has a 50 day moving average of $11.42 and a 200-day moving average of $8.94.

SeaSpine Holdings Corporation (NASDAQ:SPNE) last released its quarterly earnings results on Thursday, August 3rd. The medical equipment provider reported ($0.68) EPS for the quarter, topping analysts’ consensus estimates of ($0.79) by $0.11. SeaSpine Holdings Corporation had a negative net margin of 31.16% and a negative return on equity of 34.71%. On average, analysts forecast that SeaSpine Holdings Corporation will post ($2.77) earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://www.thecerbatgem.com/2017/08/04/seaspine-holdings-corporation-nasdaqspne-earns-buy-rating-from-analysts-at-hc-wainwright-updated-updated-updated.html.

Several large investors have recently bought and sold shares of the stock. Russell Investments Group Ltd. increased its stake in SeaSpine Holdings Corporation by 120.8% in the second quarter. Russell Investments Group Ltd. now owns 244,247 shares of the medical equipment provider’s stock worth $2,814,000 after buying an additional 133,625 shares during the last quarter. Acadian Asset Management LLC bought a new stake in SeaSpine Holdings Corporation during the second quarter worth $366,000. Spark Investment Management LLC increased its stake in SeaSpine Holdings Corporation by 14.4% in the second quarter. Spark Investment Management LLC now owns 58,000 shares of the medical equipment provider’s stock worth $668,000 after buying an additional 7,300 shares during the last quarter. Hodges Capital Management Inc. acquired a new stake in SeaSpine Holdings Corporation during the second quarter valued at approximately $1,382,000. Finally, Schwab Charles Investment Management Inc. increased its stake in SeaSpine Holdings Corporation by 1.0% in the second quarter. Schwab Charles Investment Management Inc. now owns 18,707 shares of the medical equipment provider’s stock valued at $216,000 after buying an additional 190 shares in the last quarter. Institutional investors own 47.48% of the company’s stock.

SeaSpine Holdings Corporation Company Profile

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.

Receive News & Stock Ratings for SeaSpine Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine Holdings Corporation and related stocks with our FREE daily email newsletter.